Clinical Trial Update: Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial in Korean breast cancer patients evaluated the safety and efficacy of pegteograstim; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pegteograstim (pegteograstim)

Snippet

Sponsor: Yonsei University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED